Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 117876
Published online Aug 15, 2026. doi: 10.4251/wjgo.v18.i8.117876
Published online Aug 15, 2026. doi: 10.4251/wjgo.v18.i8.117876
Table 1 Sequences of all primers
| Primer | Sequence (5’-3’) |
| CCN1 | F: ATAGTATCAAGGACCCCA |
| R: CTCCATTCCAAAAACAGG | |
| CCN2 | F: TCTGTCACTTCGGCTCCCC |
| R: CTCGTCACACACCCACTCC | |
| AMOTL2 | F: AGGTGCCCCAGGTGGTAGC |
| R: GGAATGTCGGATGAGAGTG | |
| ASAP3 | F: GAGTGTGAGGCGTGGGTG |
| R: CTTTGTGAGGTCGTGCGG | |
| GAPDH | F: GGAGCGAGATCCCTCCAAAAT |
| R: GGCTGTTGTCATACTTCTCATGG |
- Citation: Huang XB, Deng Y, Gong SY, Yu M, Cai H. ASAP3 disrupts ASAP1-ARHGAP12 to inhibit RhoA and yes-associated protein/transcriptional coactivator with PDZ-binding motif, suppressing gastric cancer progression. World J Gastrointest Oncol 2026; 18(8): 117876
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/117876.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i8.117876